Aspirin Foundation
Search
What is Aspirin?Uses of AspirinSuitabilityNews & EventsAbout the FoundationContact Us
  Home > News and Events > Media Releases > Another landmark for the world's wonder drug
News and Events man reading a news paper



News Briefs

Media Releases

Conferences
Photo Library





MEDIA RELEASE


23rd February 2006


"Epidemic of fear" stopping life-saving aspirin?


People at risk of a heart attack may be discouraged from taking low dose aspirin because of a misplaced concern over perceived side effects on the stomach. Professor James F Fries, Professor of Medicine at Stanford University School of Medicine, USA1 believes that, “The general public has been suffering from an epidemic of fear” over this issue.

Low-dose aspirin (75mg/day) is recommended for people who have already had a heart attack or who are at increased risk of having one2,3. But worry that it may cause stomach problems due to gastric irritation could be stopping some people from taking this life-saving treatment.

"It's time to roll back this view as people may be depriving themselves of the benefits of aspirin in myocardial infarction," Professor Fries said. He added that this belief had arisen some time ago in the days when very high doses of aspirin (4.8 g/day) were used to treat arthritis for prolonged periods at a time.

Some people may also worry that they cannot use aspirin as a painkiller if they are taking low-dose aspirin for a heart condition but Professor Fries reassures them. “In my experience 1.2g/day is the right dose for acute pain and aspirin is one of the safest NSAIDs,” he said. "You can add OTC analgesic doses4 to daily cardiac doses very easily. Data clearly favour the use of aspirin in people over 50 years old - it has a cardiac dividend that trumps everything else."

Note: A small minority of people may be sensitive to even small doses of aspirin but overall its benefits far outweigh the risks.
ENDS

Notes to editors
1. Professor James Fries has published many important papers on the gastrointestinal effects of NSAIDs. Some recent examples are:

Fries JF, Murtagh KN, Bennett M, Zatarain E, Lingala B, Bruce B.
The rise and decline of nonsteroidal anti-inflammatory drug-associated
gastropathy in rheumatoid arthritis. Arthritis Rheum 2004 ;50:2433-40

Fries JF, Bruce B. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 2003;30:2226-33

Henry D, Lim LL, Garcia Rodriguez LA, Perez Gutthann S, Carson JL, Griffin
M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Br Med J 1996;312:1563-6

2. The latest guideline from the Joint British Societies (Heart 2005;91:1-52) recommends low-dose aspirin (75 mg/day) for:
• all people with coronary or peripheral atherosclerotic disease, for life
• as secondary prevention of stroke and vascular events in people with a history of stroke or transient ischaemic attack (with dipyridamole), for two years
• for all people over the age of 50 years who have a total cardiovascular disease risk >20%, and in selected people with diabetes (>50 years, or who are younger but have had the disease for more than 10 years, or who are already receiving treatment for hypertension), once blood pressure has been controlled

3. Further information about the benefits of aspirin is available at www.aspirin-foundation.com

4. The recommended dose of OTC aspirin for the short-term treatment of pain is 0.3 - 1 g every 6 hours up to a maximum of 4 times a day.